Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DR26F56EU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $79,035
Award facts
- Contract value 100% obligated
- $79,034.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $79,034.62 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL syringes on November 20, 2025, with an ultimate completion date of November 21, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and represents a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical support vehicle valued at $999.99 million through December 2026. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Health Agency and other government entities. As the prime contractor on this delivery order, the company supplies brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Dupixent is a biologic medication used to treat conditions such as atopic dermatitis, asthma, and eosinophilic esophagitis, underscoring the company's role in delivering specialized pharmaceutical products essential to military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F56EU?
SPE2DR26F56EU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26F56EU worth?
The government has obligated $79,035 on SPE2DR26F56EU.
Is contract SPE2DR26F56EU an order under another contract?
Yes. SPE2DR26F56EU is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F56EU competed?
The extent of competition for SPE2DR26F56EU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award